Literature DB >> 33856812

Enhancing Top-Down Proteomics of Brain Tissue with FAIMS.

James M Fulcher1, Aman Makaju2, Ronald J Moore1, Mowei Zhou3, David A Bennett4, Philip L De Jager5, Wei-Jun Qian1, Ljiljana Paša-Tolić3, Vladislav A Petyuk1.   

Abstract

Proteomic investigations of Alzheimer's and Parkinson's disease have provided valuable insights into neurodegenerative disorders. Thus far, these investigations have largely been restricted to bottom-up approaches, hindering the degree to which one can characterize a protein's "intact" state. Top-down proteomics (TDP) overcomes this limitation; however, it is typically limited to observing only the most abundant proteoforms and of a relatively small size. Therefore, fractionation techniques are commonly used to reduce sample complexity. Here, we investigate gas-phase fractionation through high-field asymmetric waveform ion mobility spectrometry (FAIMS) within TDP. Utilizing a high complexity sample derived from Alzheimer's disease (AD) brain tissue, we describe how the addition of FAIMS to TDP can robustly improve the depth of proteome coverage. For example, implementation of FAIMS with external compensation voltage (CV) stepping at -50, -40, and -30 CV could more than double the mean number of non-redundant proteoforms, genes, and proteome sequence coverage compared to without FAIMS. We also found that FAIMS can influence the transmission of proteoforms and their charge envelopes based on their size. Importantly, FAIMS enabled the identification of intact amyloid beta (Aβ) proteoforms, including the aggregation-prone Aβ1-42 variant which is strongly linked to AD. Raw data and associated files have been deposited to the ProteomeXchange Consortium via the MassIVE data repository with data set identifier PXD023607.

Entities:  

Keywords:  Alzheimer’s; FAIMS; brain tissue; differential mobility spectrometry; ion mobility; top-down proteomics

Mesh:

Substances:

Year:  2021        PMID: 33856812      PMCID: PMC8672206          DOI: 10.1021/acs.jproteome.1c00049

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  94 in total

Review 1.  Neuropeptides--an overview.

Authors:  T Hökfelt; C Broberger; Z Q Xu; V Sergeyev; R Ubink; M Diez
Journal:  Neuropharmacology       Date:  2000-06-08       Impact factor: 5.250

Review 2.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

3.  Defining Gas-Phase Fragmentation Propensities of Intact Proteins During Native Top-Down Mass Spectrometry.

Authors:  Nicole A Haverland; Owen S Skinner; Ryan T Fellers; Areeba A Tariq; Bryan P Early; Richard D LeDuc; Luca Fornelli; Philip D Compton; Neil L Kelleher
Journal:  J Am Soc Mass Spectrom       Date:  2017-04-03       Impact factor: 3.109

Review 4.  Top Down proteomics: facts and perspectives.

Authors:  Adam D Catherman; Owen S Skinner; Neil L Kelleher
Journal:  Biochem Biophys Res Commun       Date:  2014-02-17       Impact factor: 3.575

5.  Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes.

Authors:  Matthew Blatnik; Suzanne R Thorpe; John W Baynes
Journal:  Ann N Y Acad Sci       Date:  2008-04       Impact factor: 5.691

6.  Top-Down Proteomics Enables Comparative Analysis of Brain Proteoforms Between Mouse Strains.

Authors:  Roderick G Davis; Hae-Min Park; Kyunggon Kim; Joseph B Greer; Ryan T Fellers; Richard D LeDuc; Elena V Romanova; Stanislav S Rubakhin; Jonathan A Zombeck; Cong Wu; Peter M Yau; Peng Gao; Alexandra J van Nispen; Steven M Patrie; Paul M Thomas; Jonathan V Sweedler; Justin S Rhodes; Neil L Kelleher
Journal:  Anal Chem       Date:  2018-02-26       Impact factor: 6.986

7.  Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain.

Authors:  Norelle C Wildburger; Thomas J Esparza; Richard D LeDuc; Ryan T Fellers; Paul M Thomas; Nigel J Cairns; Neil L Kelleher; Randall J Bateman; David L Brody
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

8.  MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics.

Authors:  Andy T Kong; Felipe V Leprevost; Dmitry M Avtonomov; Dattatreya Mellacheruvu; Alexey I Nesvizhskii
Journal:  Nat Methods       Date:  2017-04-10       Impact factor: 28.547

9.  High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.

Authors:  Suzanne E Schindler; James G Bollinger; Vitaliy Ovod; Kwasi G Mawuenyega; Yan Li; Brian A Gordon; David M Holtzman; John C Morris; Tammie L S Benzinger; Chengjie Xiong; Anne M Fagan; Randall J Bateman
Journal:  Neurology       Date:  2019-08-01       Impact factor: 11.800

Review 10.  Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.

Authors:  James P Quinn; Nicola J Corbett; Katherine A B Kellett; Nigel M Hooper
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more
  3 in total

Review 1.  Deciphering combinatorial post-translational modifications by top-down mass spectrometry.

Authors:  Jennifer S Brodbelt
Journal:  Curr Opin Chem Biol       Date:  2022-06-29       Impact factor: 8.972

Review 2.  Subcellular Transcriptomics and Proteomics: A Comparative Methods Review.

Authors:  Josie A Christopher; Aikaterini Geladaki; Charlotte S Dawson; Owen L Vennard; Kathryn S Lilley
Journal:  Mol Cell Proteomics       Date:  2021-12-16       Impact factor: 5.911

3.  FLASHIda enables intelligent data acquisition for top-down proteomics to boost proteoform identification counts.

Authors:  Kyowon Jeong; Maša Babović; Vladimir Gorshkov; Jihyung Kim; Ole N Jensen; Oliver Kohlbacher
Journal:  Nat Commun       Date:  2022-07-29       Impact factor: 17.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.